About Us  |  Contact Us  |  Español
Woman And Infants
Woman And Infants

Trial of AMG 386, A Selective Angiopoietin 1/2 Neutralizing Peptibody

Organizations Women & Infants
Research Type Clinical
Therapeutic Area of Study Cancer - Ovarian
Recruitment Status Open
Contact Information

274-1100

Description

A Phase II Trial of AMG 386 (IND#111071), A Selective Angiopoietin 1/2 Neutralizing Peptibody, in Patients with Persistent/Recurrent Carcinoma of the Endometrium

Look for another study
banner_parentclass_210
banner_qanda_210
Woman And Infants
© 2011 Site Index | Disclaimer | Legal Notices | Talks Your Health